German cell-based fish developer Bluu Biosciences closes EUR 7 million seed funding round

Berlin, Germany-based biotech firm Bluu Biosciences, founded just ten months ago, has closed its seed funding round at EUR 7 million (USD 8.2 million), according to a 26 March announcement.

The company said it is the first in Europe specializing in cell-based fish development and production …

Photo courtesy of Bluu Biosciences